Filed: 2/14/2024ACC: 0000902664-24-001738
📋 What this filing means
ALTITUDE CREST PARTNERS INC. filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $149.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$149.44M
Total AUM (reported)
6.35M
Total Shares
Allocation by class
COM$88.54M59.2%
SPONSORED ADS$32.60M21.8%
SPONSORED ADR$11.22M7.5%
SHS$9.07M6.1%
COM CL A$8.00M5.4%
*W EXP 08/01/203$7.7K0.0%
Portfolio Concentration
Top 3$91.19M61.0%
4–10$57.63M38.6%
11–25$621.4K0.4%
Top 3 weight
61.0%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 6.35M
Sole
Full voting authority
6.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
LEGEND BIOTECH CORP
SOLEShares541.82K
TypeSH
Market value$32.60M
21.82%
Sole
541.82K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares754.56K
TypeSH
Market value$30.46M
20.38%
Sole
754.56K
Shared
0.00
None
0.00
DANAHER CORPORATION
SOLEShares121.60K
TypeSH
Market value$28.13M
18.82%
Sole
121.60K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares29.50K
TypeSH
Market value$11.22M
7.51%
Sole
29.50K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares114.04K
TypeSH
Market value$11.00M
7.36%
Sole
114.04K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares152.20K
TypeSH
Market value$9.11M
6.10%
Sole
152.20K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares808.06K
TypeSH
Market value$9.07M
6.07%
Sole
808.06K
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS LTD
SOLEShares456.04K
TypeSH
Market value$8.00M
5.35%
Sole
456.04K
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares99.13K
TypeSH
Market value$7.33M
4.91%
Sole
99.13K
Shared
0.00
None
0.00
ALIGOS THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$1.89M
1.26%
Sole
2.84M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares43.10K
TypeSH
Market value$613.7K
0.41%
Sole
43.10K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares384.57K
TypeSH
Market value$7.7K
<0.01%
Sole
384.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 541.82K | SH | $32.60M 21.82% | 541.82K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 754.56K | SH | $30.46M 20.38% | 754.56K | 0.00 | 0.00 |
DANAHER CORPORATIONSOLE | COM | 121.60K | SH | $28.13M 18.82% | 121.60K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 29.50K | SH | $11.22M 7.51% | 29.50K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 114.04K | SH | $11.00M 7.36% | 114.04K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 152.20K | SH | $9.11M 6.10% | 152.20K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 808.06K | SH | $9.07M 6.07% | 808.06K | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS LTDSOLE | COM CL A | 456.04K | SH | $8.00M 5.35% | 456.04K | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 99.13K | SH | $7.33M 4.91% | 99.13K | 0.00 | 0.00 |
ALIGOS THERAPEUTICS INCSOLE | COM | 2.84M | SH | $1.89M 1.26% | 2.84M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | COM | 43.10K | SH | $613.7K 0.41% | 43.10K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/203 | 384.57K | SH | $7.7K <0.01% | 384.57K | 0.00 | 0.00 |